DeCell Technologies has now obtained patents for its novel and innovative prECM™ decellularization technology in the U.S., Canada, and five countries in the E.U. (UK, France, Spain, Germany and Italy). These patents include process protection and for the first time ever—composition of matter protection defining the quality of decellularized tissues produced by the prECM™ process. Further, the patents also secure DeCell’s novel liquid-based soft tissue sterilization that eliminates the need for using tissue disrupting radiation or energy-based sterilization methods.
- NEWS RELEASE: BioNova supports the Government of Canada’s biomanufacturing and life sciences strategy
- Discover Halifax Podcast features BioNova Executive Director Scott Moffitt
- RESEARCH MONEY: Life sciences organizations ask Ottawa for national strategy following Sanofi investment
- THE HILL TIMES: New life sciences campaign aims to break down silos between innovation, economic development and health policies
- Sona Nanotech Closes Unbrokered Private Placement Financing for $2.26m in Gross Proceeds
- Evasc Neurovascular Announces the New eCLIPs Bifurcation Flow Diverter
- Fluence by OSRAM Debuts Products at MJBizCon 2021, Helping Cannabis Cultivators Grow Smarter Through Innovative LED Technology
- FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH
- Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies
- School of Life Sciences and Technology, Indonesia Wins XVI Fujio Cup Quiz in NCRM NICHE 2021; Rajalakshmi Engineering College, India, Emerge Runners.
- Occupational Health Experts, DriverCheck, Performs More Than 400,000 COVID-19 Tests Since Third Wave – Expands COVIDdetect DIY/at-home Testing Service
- Blade Therapeutics Initiates Additional Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis
- Avivagen Secures Large OxC-beta™ Livestock Order in Asia
- ITM and CNL Sign Memorandum of Understanding to Pursue Global Development and Production of Rare Medical Radioisotope, Actinium-225
- Patrick Daoust appointed Director of Technical Training for Canadian Alliance for Skills and Training in Life Sciences